Inactivity on the kidney transplant wait-list is associated with inferior pre-and posttransplant outcomes.
Kidney transplantation is the best treatment modality for qualified patients with end-stage renal disease (ESRD) and is associated with improved patient survival and quality of life compared with dialysis (1, 2). There are several steps involved to receive a kidney transplant (KT) including patient referral, evaluation and wait-listing for transplantation. Previous studies have examined the factors that affect likelihood of transplant evaluation referral, completion of evaluation, and wait-listing (3, 4) . Demographic differences in race and gender, and socioeconomic status have been consistently highlighted as factors among others that lead to differential access to be placed on the wait-list (WL; 4-7). Less attention has been paid to the impact of events that occur during wait-listing period on patient outcomes, despite the long period of time that qualified candidates often spend on the WL.
Once on the WL, the candidates can remain "active" (status 1 in UNET sm ) with the possibility of receiving a KT when an organ becomes available, or be temporarily "inactive" (status 7) which makes them ineligible to receive a KT. A candidate may change from active to inactive status several times prior to successful transplantation. Candidates are ultimately removed from the WL for one of three reasons: transplant, death, or delisting. While practices vary among the different transplant programs, the placement of a previously active candidate into an inactive status typically reflects a medical or non-medical acute event that makes the candidate temporarily inappropriate for transplantation with the expectation that the candidate will be appropriate for transplant once the acute event resolves. The prevalence of "inactive" candidates in a given year has been increasing in recent years likely reflecting an increase in overall medical co-morbidities (8) . How inactive status on the WL impacts clinical outcomes before and after kidney transplantation remains unclear. We hypothesized that the transition from the active to inactive status on the WL may be a surrogate marker for overall medical co-morbidity and/or complexity. We investigated the effect of WL inactivity on the clinical outcomes pre-and post-transplantation in a national cohort of wait-listed KT candidates.
Materials and methods
Using a US national transplant database provided by the Organ Procurement and Transplantation Network (OPTN)/Scientific Registry of Transplant Recipients (SRTR), we identified all adult (age ≥ 18) KT candidates who were first time actively wait-listed between January 1, 1996, and December 31, 2005. Study follow-up continued until January 31, 2010. The SRTR data system includes data on all donors, wait-listed candidates, and transplant recipients in the United States, submitted by the members of the OPTN, and has been described elsewhere (9) . The Health Resources and Services Administration (HRSA), US Department of Health and Human Services, provides oversight to the activities of the OPTN/SRTR contractors. For each candidate, we determined whether during the wait-listing period he or she ever had a change from active (status 1) to inactive status (status 7), and if so, how many times. We separated the study population into three groups: (i) active -never inactivated; (ii) inactivated once; and (iii) inactivated more than once on the WL. We excluded candidates who never had been active on the WL, listed for and/or received multi-organ transplants, repeat KT, and candidates and patients with missing wait-listing and/or subsequent transplant outcome information. The primary outcomes of the study were the rate of kidney transplantation, mortality on the WL, and death-censored post-transplant kidney graft and recipient survival.
Baseline demographics of the study groups were compared using chi-square test and ANOVA, as appropriate. An unadjusted Poisson regression model was utilized to compare the incidence rate of receiving a KT, living and/or deceased, among the three groups on the WL taking into consideration the total time spent on the WL. Kaplan-Meier methods with log-rank test were used to estimate kidney graft and recipient survival following kidney transplantation. Two sets of Cox proportional hazard models were applied for clinical outcomes before and after kidney transplantation. For the primary outcomes of time to transplantation, censored for delisting and death, and time to the WL death, censored for delisting and transplantation, the time at risk began when candidates were actively wait-listed for the first-time with wait-listing inactivity as a two-tier time-dependent covariate. As some candidates started out as inactive on the WL and subsequently moved to active status, the time interval between these two was calculated and used as one of the covariates in the multivariate analyses as well. For kidney graft and recipient survival analyses, the time at risk began with the transplantation. The demographic and baseline variables at the time of active listing and transplantation were used for multivariate analyses, respectively. The interaction term was considered and tested wherever appropriate in multivariate analyses for pre-and post-transplant mortality risk. Final models contain those variables with p < 0.10 after backward selection.
Analyses were run in SAS 9.2 (SAS Institute Inc., Cary, NC, USA), with statistical significance set at a two-sided a = 0.05. The procedures of our study were in accordance with the Helsinki Declaration of 1975.
Results
During the study period, a total of 163 802 candidates were actively wait-listed for a first-time KT. After excluding multi-organ transplant candidates and/or recipients (n = 3686), candidates who had missing follow-up information (n = 331), and candidates erroneously identified as having died and then subsequently relisted (n = 11), there were 159 774 candidates available for analysis. The mean age of wait-listed candidates was 49.7 AE 13.0 yr. African Americans (AA) accounted for 29.6% (47 240) and males for 59.4% (94 904) of the study population. Among all WL candidates, 37 823 (23.7%) experienced one and 10 775 (6.7%) candidates experienced more than one period of WL inactivity. Demographic characteristics of the study population are shown in Table 1 . In general, the candidates who had been placed on inactive status at least once while on the WL tended to be older, heavier, and more likely AA. Inactivated candidates were less often college-educated and experienced longer dialysis times and were more likely to be sensitized. Furthermore, candidates who experienced inactivity displayed more medical co-morbidities such as diabetes mellitus (DM) and cardiovascular disease (CVD).
The distribution of study outcomes among candidates in the three groups at the end of study follow-up are shown in Fig. 1 . In the univariate analysis, compared with candidates never inactivated on the WL, the overall transplantation rate was significantly lower for candidates who were inactive either once or more than once (407.8 AE 3.3, 101.9 AE 2.0 and 90.2 AE 3.1 transplants per 1000 patient-years, respectively, p < 0.001 for both E436 comparisons;
Fig. 2).
Inactivity negatively impacted transplant rates of both living and deceased donor KT. The effect of inactivity persisted even when only active time was considered to calculate transplant rates (data not shown). Multivariate Cox regression analyses with WL inactivity as a time-dependent variable showed that inactivity once or more than once while on the WL was associated with 42% and 27% lower likelihood of receiving a KT (HR 0.58, 95% CI 0.57, 0.59, p < 0.001, and HR 0.73, 95% CI 0.71, 0.75, p < 0.001, respectively). Other variables independently associated with the low likelihood of kidney transplantation included AA race (HR 0.50, 95% CI 0.49, 0.51, p < 0.001), medical co-morbidities such as DM (HR 0.83, 95% CI 0.82, 0.84, p < 0.001) or CVD (HR 0.92, 95% CI 0.91, 0.94, p < 0.001), lower education levels (p < 0.001), and longer dialysis time (p < 0.001) ( Table 2 ). In contrast, PRA level >80 (HR 1.20, 95% CI 1.15, 1.26, p < 0.001) and having a private insurance (HR 1.20, 95% CI 1.19, 1.22, p < 0.001) were associated with higher likelihood of receiving kidney transplantation.
We further analyzed mortality risk for all candidates on the WL according to their history of inactive status following the initial active listing, again using WL inactivity as a two-tier time-dependent variable. Compared with the candidates who were never placed in inactive status, the risk of WL death was 94% higher in candidates inactivated once (HR 1.94, 95% CI 1.88, 2.00, p < 0.001) and 113% higher in candidates inactivated more than once (HR 2.13, 95% CI 2.02, 2.24, p < 0.001). The high mortality risk was primarily contributed by death during inactive periods in the later follow-up (Table 3) . Among 102 340 WL candidates who received a KT during the study period, 83 284 (81.3%) never experienced inactivity and waited a median of 1.1 yr (0.4, 2.4). A total of 14 589 (14.3%) experienced one inactive period and 4467 (4.4%) more than one inactive period on the WL, with median times to KT of 2.7 (1.4, 4.2) and 3.6 (2.4, 5.0) yr, respectively. Significant differences in many of demographic and baselines variables were again observed among patients of three groups which appeared to favor patients who never experienced WL inactivity (supplementary table) . After excluding transplant recipients with missing follow-up information (n = 1038), death-censored kidney graft survival was similar among the three groups during the follow-up by Kaplan-Meier estimate (log-rank p = 0.307; Fig. 3 ), which was confirmed in multivariate Cox regression analyses (data not shown). Patient survival, however, appeared inferior among candidates who had experienced more than one period of WL inactivity compared with those who were never inactive (log-rank, p < 0.001; Fig. 4) . Specifically, the mortality risk for KT recipients with a history of WL inactivity more than once compared with never inactive recipients was significantly higher (HR 1.14, 95% CI 1.05, 1.23, p = 0.001). In addition, old age (HR 1.04, 95% CI 1.04, 1.04, p < 0.001), a history of DM (HR 1.74, 95% CI 1.69, 1.78, p < 0.001), and a history of CVD (HR 1.33, 95% CI 1.29, 1.38, p < 0.001) were associated with higher post-transplant mortality (Table 4) .
Not surprisingly, at the end of study follow-up, a smaller proportion of WL candidates from the never inactive group remained either waiting for KT or experienced delisting compared WL candidates with a history of inactivity during the WL period.
Discussion
Periods of WL inactivity are typically conceived as a response to acute events that have resolved when the candidate is reactivated. However, there appears to be a persistent impact of inactive episodes. We found that inactive status was associated with lower transplantation rate and higher mortality on the WL. Furthermore, even among patients who ultimately received a KT, a prior history of repeated inactivity on the WL predicted higher post-transplant mortality. A previous study by Delmonico and McBride described high rate of death among candidates in inactive status although they did not provide detail on how often those candidates were active during wait-listing and did not compare inactive to active candidates (8) . Our findings suggest that in candidates who were initially suitable for active listing, subsequent periods of inactive status are associated with an increased mortality risk, with most death occurring during the periods of inactivity. Thus, inactive status appears to be a surrogate for risk factors, particularly CVD risks that are not adequately captured by current transplant evaluation or WL screenings. Our findings are consistent with a number of studies that have highlighted the inadequacy of current screening techniques to adequately stratify the CVD risk in KT candidates (10) (11) (12) . Further investigation into the reasons for candidates being placed in inactive status may help explain the observed mortality and prevent the events leading to WL inactivity and/or death. We observed more pre-emptive listing, shorter dialysis times, and subsequently more pre-emptive KT among candidates who were never inactive on the WL. Less exposure to dialysis may be one of the reasons for less WL inactivity and better posttransplant survivals. Previous studies have documented the benefits of pre-emptive transplantation on kidney and recipient survival (13) (14) (15) . In fact, one recent study showed that the negative impact of end-stage kidney disease on post-transplantation outcomes was mainly an effect of dialysis duration prior to wait-listing (16) . Thus, our current findings were consistent with the above observations and reinforce the importance of early access to the WL and to transplantation for optimal outcomes.
Higher transplantation rate for candidates from the active group was not only limited to deceased donor KT. In fact, substantially more live donor transplants were also performed among candidates in the never inactive group. The reasons for more live donor transplants are not readily apparent from the WL demographics. Clearly, there are factors present in the active group or missing in the inactive groups that increase the likelihood of live donor transplantation. These factors, not captured by the use of current national registry data, could include differences in economic/income status, family structure, and social support, and even the extent of pre-ESRD/pre-listing care from a specialist (17) (18) (19) . Whether the lower transplantation rate and high mortality among candidates in the inactive groups on the WL are actual consequence of demographic differences remains unclear. Elucidating the reasons behind the WL inactivity may prove very important to WL management and ultimately transplant outcomes.
The strongest predictor for WL mortality was experiencing inactivity independent of other baseline variables including reported medical co-morbidities such as DM and CVD. Based on our current observations, we would argue for the need of dedicated attention paid by the transplant programs/providers to WL candidates who are placed in inactive status to understand the reasons leading to such inactivity and to maximize medical health while on the WL. A first inactive event may provide an opportunity to reevaluate a candidate's health status and to ensure the optimal WL management of that particular candidate.
Our study has several limitations. First, it is a retrospective registry study, and as such we are limited from making any causal claims of observed association between WL inactivity and pre-and post-transplant outcomes. Second, the lack of granularity in the registry data utilized limits our ability to fully understand the reasons behind events leading to WL inactivity and/or delisting, even when an apparent reason is listed. Third, individual-level variables such as income, family structure and/or social support, and existence of pre-ESRD/pre-listing care, clearly important to overall patient outcomes, are not available; thus, their contribution to WL inactivity remain unknown. Finally, some transplant programs routinely place all transplant candidates on the WL initially in inactive status in order for candidates to accrue the waiting time, while the transplant evaluation is being completed. By including only candidates who had experienced at least one period of activity, we may eliminated from analysis a cohort of candidates who might never be suitable to kidney transplantation, biasing our results.
In conclusion, WL inactive status appears to be a surrogate for medical and perhaps socioeconomic co-morbidities and was associated with a decreased transplant opportunity and an increased risk of WL and post-transplant death. Increased attention should be paid by transplant programs and providers to candidates who require periods of inactivity. A better understanding of the factors associated with inactive status may improve risk stratification, WL management, and ultimately pre-and post-transplant survival.
